Back

Integrated analysis of stemness-associated immune modulatory circuits in squamous cell carcinomas

Guo, W.; Leon, D.; Luan, J.; Gang, A.; Huang, X.; Nicholson, B.; Dorosz, K.; Zhao, Y. S.; Grimshaw, S.; Bolotin, D.; Lingen, M. W.; Vokes, E. E.; Pearson, A.; Rosenberg, A. J.; Shen, L.; Izumchenko, E.; Agrawal, N.; Jiang, J.; Miao, Y. P.

2026-04-06 cancer biology
10.64898/2026.04.02.716182 bioRxiv
Show abstract

Emerging evidence indicates that a subset of cancer cells enriched for stemness-related gene signatures possess distinct immunomodulatory capacities, enabling these tumor-initiating stem cells (tSCs) to more effectively evade or resist anti-tumor immunity. Despite these advances, the tSC-specific molecular circuits orchestrating their specialized immune privilege program are not well defined. Here, in squamous cell carcinomas of the skin and oral cavity, we comprehensively delineate the unique immune-evasive properties of tSCs and dissect the transcriptional regulation shaping their immunomodulatory programs. By integrating transcriptome profiling, chromatin landscape mapping, genetic perturbation, and single-cell RNA sequencing, we found that the tSC-specific immune program is broadly governed by SOX2, a stemness-associated transcription factor. We demonstrate that SOX2 enables tSCs to sustain immature tumor-associated neutrophils (TANs) and subsequently trigger these myeloid cells to foster the development of tumor-associated macrophages (TAMs). This SOX2-directed tSC-TAN-TAM axis establishes a localized immunosuppressive niche for protecting tSC. SIGNIFICANCEHere, we uncover SOX2 as a master regulator that orchestrates conserved immune modulatory circuits in tSCs to sustain pro-tumor myeloid cell states. These findings place tSCs at the apex of immune landscape remodeling, asserting a central role of stemness-associated program in organizing the immunosuppressive tumor microenvironment.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Cell Stem Cell
57 papers in training set
Top 0.1%
9.8%
2
Nature
575 papers in training set
Top 3%
9.8%
3
Nature Communications
4913 papers in training set
Top 25%
7.0%
4
Cancer Discovery
61 papers in training set
Top 0.2%
7.0%
5
Nature Cell Biology
99 papers in training set
Top 0.5%
6.6%
6
Cell Reports
1338 papers in training set
Top 6%
6.6%
7
Science
429 papers in training set
Top 7%
4.7%
50% of probability mass above
8
Journal of Experimental Medicine
106 papers in training set
Top 0.6%
4.5%
9
Developmental Cell
168 papers in training set
Top 5%
3.9%
10
eLife
5422 papers in training set
Top 27%
3.5%
11
Immunity
58 papers in training set
Top 2%
3.5%
12
Molecular Cell
308 papers in training set
Top 5%
3.0%
13
Cancer Research
116 papers in training set
Top 1%
2.5%
14
Cancer Cell
38 papers in training set
Top 0.8%
2.0%
15
Nature Cancer
35 papers in training set
Top 0.6%
2.0%
16
Cell
370 papers in training set
Top 10%
2.0%
17
Science Advances
1098 papers in training set
Top 19%
1.6%
18
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.4%
19
Nature Genetics
240 papers in training set
Top 5%
1.3%
20
Nature Immunology
71 papers in training set
Top 1%
1.2%
21
Blood
67 papers in training set
Top 1%
1.1%
22
Cell Genomics
162 papers in training set
Top 5%
0.9%
23
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
24
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
25
Cell Systems
167 papers in training set
Top 11%
0.8%
26
Cell Reports Medicine
140 papers in training set
Top 10%
0.6%